Home
Conditions
Eye Neoplasms

Clinical trial condition

Eye Neoplasms

Explore clinical trials studying Eye Neoplasms. Study availability and eligibility vary by location and protocol.

396 public trials 62 recruiting studies

Refine in advanced search Browse all conditions

Eye Neoplasms trial results

Completed

Vaccine Therapy and Monoclonal Antibody Therapy in Treating Patients With Stage IV Melanoma

NCT00032045

Conditions: Eye Diseases, Eye Neoplasms, Intraocular Melanoma, +16 more
Locations: Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States

View Trial Details

Completed

Temozolomide and Thalidomide in Treating Patients With Stage III or Stage IV Melanoma

NCT00005815

Conditions: Eye Diseases, Eye Neoplasms, Intraocular Melanoma, +16 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy

NCT00066599

Conditions: Agranulocytosis, Blast Crisis, Blood Protein Disorders, +89 more
Locations: Children's Hospital of Orange County Orange, California, United States

Children's Hospital and Health Center, San Diego San Diego, California, United States

Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States

Duke Comprehensive Cancer Center Durham, North Carolina, United States

View Trial Details

Completed

ZD0473 and Doxorubicin in Treating Patients With Advanced Solid Tumors or Lymphoma

NCT00016172

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +43 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Temozolomide and Interferon Alfa in Treating Patients With Stage III or Stage IV Melanoma

NCT00027742

Conditions: Eye Diseases, Eye Neoplasms, Intraocular Melanoma, +16 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Pyroxamide in Treating Patients With Advanced Cancer

NCT00042900

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +90 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

BCX-1777 in Treating Patients With Refractory Cancer

NCT00073944

Conditions: Adenocarcinoma, Adenocarcinoma Of Esophagus, Adnexal Diseases, +140 more
Locations: Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Long Term Results of Combined Transpupillary Thermotherapy (TTT) Indocyanine Green (ICG) Based Photodynamic Therapy (PDT) in Choroidal Melanoma

NCT01253759

Conditions: Choroidal Melanoma, Eye Diseases, Eye Neoplasms, +12 more
Locations: New England Retina Associates Hamden, Connecticut, United States

View Trial Details

Completed

PXD101 and Bortezomib in Treating Patients With Advanced Solid Tumors or Lymphomas

NCT00348985

Conditions: Adult Grade III Lymphomatoid Granulomatosis, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +109 more
Locations: University of Colorado Denver, Colorado, United States

View Trial Details

Completed

PEG-Interferon Alfa-2b and Thalidomide in Treating Patients With Recurrent or Metastatic Melanoma

NCT00238329

Conditions: Eye Diseases, Eye Neoplasms, Intraocular Melanoma, +16 more
Locations: Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States

View Trial Details

Eye Neoplasms

Eye Neoplasms trial results

Related conditions